FMED vs GNOM
Fidelity Disruptive Medicine ETF against Global X Genomics & Biotechnology ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
26%
14 shared positions
Fee gap
0 bp
same fee
1-year return gap
33.7 pts
GNOM is ahead
Larger fund
GNOM
$110M
Side by side
| FMED | GNOM | |
|---|---|---|
| Fund | Fidelity Disruptive Medicine ETF | Global X Genomics & Biotechnology ETF |
| Issuer | Fidelity | Global X |
| Category | Internet & Innovation | Biotech & Health Innovation |
| Expense ratio | 0.50% | 0.50% |
| Assets | $52M | $110M |
| Average daily dollar volume | $299K | $2.5M |
| Listed | Apr 16, 2020 | Apr 5, 2019 |
| FrenzyCap score | 44 | 49 |
| 1-month return | −1.2% | −0.8% |
| 3-month return | +12.1% | +25.2% |
| Year to date | +18.3% | +51.2% |
| 1-year return | +20.6% | +54.3% |
| 30-day volatility | 28.9% | 41.3% |
| Worst drawdown, 1 year | −18.3% | −18.2% |
| Trailing 12-month yield | — | 0.94% |
| Holdings | 77 | 52 |
| Top 10 weight | 34.4% | 55.6% |
| Look-through P/E | — | — |
| Holdings vs fair value | −0.9% | +0.4% |
| Holdings above 200-day average | 78% | 75% |
| Net flow, latest 3 reported months | −$17M thru May 2026 | +$1.4M thru May 2026 |
| 30-day implied volatility | 51.8% | 38.0% |
| Holdings as of | as of Oct 20, 2026issuer data | as of Oct 21, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
29% of FMED · 55% of GNOM
Sector mix of the stock holdings
| Sector | FMED | GNOM | Gap |
|---|---|---|---|
| Health Care | 74.6% | 80.4% | −5.7% |
| Technology | 20.4% | 14.7% | +5.7% |
More: full overlap table · FMED holdings · GNOM holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.